Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 1
2018 2
2019 4
2020 4
2021 2
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.
Schmassmann P, Roux J, Buck A, Tatari N, Hogan S, Wang J, Rodrigues Mantuano N, Wieboldt R, Lee S, Snijder B, Kaymak D, Martins TA, Ritz MF, Shekarian T, McDaid M, Weller M, Weiss T, Läubli H, Hutter G. Schmassmann P, et al. Among authors: tatari n. Sci Transl Med. 2023 Jul 19;15(705):eadf5302. doi: 10.1126/scitranslmed.adf5302. Epub 2023 Jul 19. Sci Transl Med. 2023. PMID: 37467314
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Bassey-Archibong BI, Rajendra Chokshi C, Aghaei N, Kieliszek AM, Tatari N, McKenna D, Singh M, Kalpana Subapanditha M, Parmar A, Mobilio D, Savage N, Lam F, Tokar T, Provias J, Lu Y, Chafe SC, Swanton C, Hynds RE, Venugopal C, Singh SK. Bassey-Archibong BI, et al. Among authors: tatari n. Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2205247120. doi: 10.1073/pnas.2205247120. Epub 2023 Feb 13. Proc Natl Acad Sci U S A. 2023. PMID: 36780531 Free PMC article.
Advances in Immunotherapy for Adult Glioblastoma.
Chokshi CR, Brakel BA, Tatari N, Savage N, Salim SK, Venugopal C, Singh SK. Chokshi CR, et al. Among authors: tatari n. Cancers (Basel). 2021 Jul 7;13(14):3400. doi: 10.3390/cancers13143400. Cancers (Basel). 2021. PMID: 34298615 Free PMC article. Review.
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.
Chokshi CR, Shaikh MV, Brakel B, Rossotti MA, Tieu D, Maich W, Anand A, Chafe SC, Zhai K, Suk Y, Kieliszek AM, Miletic P, Mikolajewicz N, Chen D, McNicol JD, Chan K, Tong AHY, Kuhlmann L, Liu L, Alizada Z, Mobilio D, Tatari N, Savage N, Aghaei N, Grewal S, Puri A, Subapanditha M, McKenna D, Ignatchenko V, Salamoun JM, Kwiecien JM, Wipf P, Sharlow ER, Provias JP, Lu JQ, Lazo JS, Kislinger T, Lu Y, Brown KR, Venugopal C, Henry KA, Moffat J, Singh SK. Chokshi CR, et al. Among authors: tatari n. Nat Med. 2024 Aug 2. doi: 10.1038/s41591-024-03138-9. Online ahead of print. Nat Med. 2024. PMID: 39095594
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.
Tatari N, Khan S, Livingstone J, Zhai K, Mckenna D, Ignatchenko V, Chokshi C, Gwynne WD, Singh M, Revill S, Mikolajewicz N, Zhu C, Chan J, Hawkins C, Lu JQ, Provias JP, Ask K, Morrissy S, Brown S, Weiss T, Weller M, Han H, Greenspoon JN, Moffat J, Venugopal C, Boutros PC, Singh SK, Kislinger T. Tatari N, et al. Acta Neuropathol. 2022 Dec;144(6):1127-1142. doi: 10.1007/s00401-022-02506-4. Epub 2022 Sep 30. Acta Neuropathol. 2022. PMID: 36178522 Free PMC article.
Wnt activation as a therapeutic strategy in medulloblastoma.
Manoranjan B, Venugopal C, Bakhshinyan D, Adile AA, Richards L, Kameda-Smith MM, Whitley O, Dvorkin-Gheva A, Subapanditha M, Savage N, Tatari N, McKenna D, Bassey-Archibong B, Winegarden N, Hallett R, Provias JP, Yarascavitch B, Ajani O, Fleming A, Bader GD, Pugh TJ, Doble BW, Singh SK. Manoranjan B, et al. Among authors: tatari n. Nat Commun. 2020 Aug 28;11(1):4323. doi: 10.1038/s41467-020-17953-4. Nat Commun. 2020. PMID: 32859895 Free PMC article.
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Vora P, Venugopal C, Salim SK, Tatari N, Bakhshinyan D, Singh M, Seyfrid M, Upreti D, Rentas S, Wong N, Williams R, Qazi MA, Chokshi C, Ding A, Subapanditha M, Savage N, Mahendram S, Ford E, Adile AA, McKenna D, McFarlane N, Huynh V, Wylie RG, Pan J, Bramson J, Hope K, Moffat J, Singh S. Vora P, et al. Among authors: tatari n. Cell Stem Cell. 2020 Jun 4;26(6):832-844.e6. doi: 10.1016/j.stem.2020.04.008. Epub 2020 May 27. Cell Stem Cell. 2020. PMID: 32464096 Free article.
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.
Manoranjan B, Chokshi C, Venugopal C, Subapanditha M, Savage N, Tatari N, Provias JP, Murty NK, Moffat J, Doble BW, Singh SK. Manoranjan B, et al. Among authors: tatari n. Oncogene. 2020 Feb;39(7):1590-1599. doi: 10.1038/s41388-019-1086-x. Epub 2019 Nov 6. Oncogene. 2020. PMID: 31695152
Embryonic Stem Cell Models of Human Brain Tumors.
Morrison LC, Tatari N, Werbowetski-Ogilvie TE. Morrison LC, et al. Among authors: tatari n. Methods Mol Biol. 2019;1869:127-142. doi: 10.1007/978-1-4939-8805-1_12. Methods Mol Biol. 2019. PMID: 30324520
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, Khoo A, Salim SK, Archibong-Bassey B, Gwynne W, Brown K, Murtaza N, Bakhshinyan D, Vora P, Venugopal C, Moffat J, Kislinger T, Singh S. Seyfrid M, et al. Among authors: tatari n. J Immunother Cancer. 2022 Jan;10(1):e003289. doi: 10.1136/jitc-2021-003289. J Immunother Cancer. 2022. PMID: 35017149 Free PMC article.
22 results